Evidence 1
Activity
Activity
50% Cytotoxicity
Toxicity
40.27 µM
Cytotoxic
50% Cytotoxicity | 40.27 | µM | target cell: Human PBMC
Target
Human PBMC
Source & Reference
NA
DBAASP
Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors With Extremely Potent and Long-Lasting Antiviral Activity. | J Virol | 2019